| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |